Synapse - Clinical Pharmacy Specialists

Search Within

Clinical Pharmacy Specialists

Results (297)

Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma

Meeting Abstract

Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
Blood (2023)

Fulltext@MSK | Save

Precision management of a patient with dihydropyrimidine dehydrogenase deficiency and liver-predominant metastatic rectal cancer using hepatic arterial floxuridine

Journal Article

Lumish, M.; Thackray, J.; Do, R. K. G.; Caudle, K. E.; Amstutz, U.; Schwab, M.; Diasio, R. B.; Jarnagin, W. R.; Cercek, A.
JCO Precision Oncology (2023)

Fulltext@MSK | Save

Response of thrombopoietin receptor agonists in MDM2 inhibitor induced thrombocytopenia

Meeting Abstract

DeMatteo, R.; Sgroe, E.; Merrill, M. B.; Gounder, M.; Liu, D.
Annals of Oncology (2023)

Fulltext@MSK | Save

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

Journal Article

Laracy, J. C.; Yan, J.; Steiger, S. N.; Tan, C. A.; Cohen, N.; Robilotti, E. V.; Fender, J.; Cohen, S.; Korde, N.; Lee-Teh, M.; more...
Haematologica (2023)

Fulltext@MSK | Save

Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network

Journal Article

Booth, J. P.; Kennerly-Shah, J. M.; Kelley, L. R.; Capozzi, D.; Prescott, H. A.; Soefje, S. A.; Pace, M. B.; Barbour, S. Y.; Tizon, R. F.; DeVincenzo, S.; more...
Journal of Oncology Pharmacy Practice (2023)

Fulltext@MSK | Save

Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant

Journal Article

Lin, A.; Brown, S.; Chinapen, S.; Lee, Y. J.; Seo, S. K.; Ponce, D. M.; Shahid, Z.; Giralt, S.; Papanicolaou, G. A.; Perales, M. A.; more...
Blood Advances (2023)

Fulltext@MSK | Save

Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Meeting Abstract

Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma

Meeting Abstract

Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function

Meeting Abstract

Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC

Meeting Abstract

Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save